loader
A wholly owned subsidiary and the investment banking arm of State Bank of India
✕

As India’s investment bank of choice and reputed corporate advisory partner, we offer comprehensive services backed by three decades of industry experience. See what makes this possible.

We help clients access insightful advice, plan for growth, gain and deploy capital, and harness their full potential, so they can succeed in the constantly changing business world.

From unique initiatives for the Indian Government to landmark deals – see what’s the latest at SBICAP.

Our innovative solutions help clients address critical business questions. We’ve received recognition for our services, year after year, both domestically and at international forums.

We aim to hire and nurture the best talent and offer a fulfilling career path for our people. This intellectual capital gives us a competitive edge.

✕
pharma-healthcare

Pharma & Healthcare

SBICAP has advised and provided services for varied businesses in the Healthcare segment. This includes biotechnology, diagnostics, life sciences, healthcare services, medical devices, and pharmaceutical businesses.

Select Transactions

Glenmark Life Sciences Limited
Value: INR 1513.6 Cr
IPO
2021
GLENMARK LIFE SCIENCES LTD.
Value: INR 1,513.60 Cr
IPO
2021
WINDLAS BIOTECH LTD.
Value:
IPO
2021
TARSONS PRODUCTS LTD.
Value: INR 1,023.54 Cr
IPO
2021
Windlas Biotech
Value: INR 401.5 Cr
IPO
2021
LAURUS LABS Limited
Value: INR 1,330.51 Cr
All Equity Capital Market Transaction
2016
Neuland Laboratories Limited
Value: INR 25 Cr
Rights Issue
2014

Connect with us